Dr. Shantanu Gaur is the co-founder and CEO of Allurion Technologies. Together with his partners, Shantanu has overseen Allurion’s fundraising, research and development, clinical programs, and commercial operations since the company’s inception.

Allurion’s mission is to help people realize their full potential with innovative, scalable, and trusted experiences. Specifically, the company has developed what Shantanu calls “Weight Loss 2.0” experiences that are more effective than diet and exercise but safer, cheaper, and more frictionless than weight loss surgery. Allurion’s flagship experience features the Elipse® Balloon—the world’s first and only procedureless gastric balloon for weight loss. The Elipse is now available for commercial sale internationally, where over 30,000 people have already been treated. The balloon is accompanied by a personalized nutritional coaching program, Allurion’s Bluetooth®-connected scale, and the Allurion Smartphone App that tracks weight loss over time and keeps consumers connected with their care team. On average, consumers lose 30 pounds in 4 months on the Elipse Program.

Since Allurion’s inception in 2009, the company has raised over $80 million. The company is headquartered in Natick, MA with offices in Paris, Dubai, and Hong Kong. Allurion has been recognized as one of Fierce Medical Device’s Fierce 15, one of Boston’s 50onFire, and a top Emerging Technology by SAGES.

Shantanu is an inventor on over 40 patents and has authored multiple peer-reviewed publications. He has been featured on CNBC and Bloomberg and invited to speak on Allurion, obesity, and medical device innovation at numerous worldwide events.

Shantanu graduated summa cum laude with a B.S. in Biology from Harvard College and with an M.D. from Harvard Medical School, where he was a Paul Revere Frothingham Scholar and Paul & Daisy Soros Fellow. He is originally from Bethel Park, PA and now lives in Dover, MA with his wife Neha and son Yuvraj.